The zebrafish: A model to study the endogenous mechanisms of pain

ILAR Journal

Volumn 50, Issue 4, 2009, Pages 373-386

  Gonzalez Nunez, Veronica ^a   Rodríguez, Raquel E ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Embryonic development; Opiates; Opioid peptides; Opioid receptors; Pain; Pharmacology; Zebrafish

Indexed keywords

DANIO RERIO; MAMMALIA; VERTEBRATA;

OPIATE PEPTIDE; OPIATE RECEPTOR;

ANIMAL; ANIMAL MODEL; ARTICLE; METABOLISM; PAIN; PHYSIOLOGY; ZEBRA FISH;

ANIMALS; MODELS, ANIMAL; OPIOID PEPTIDES; PAIN; RECEPTORS, OPIOID; ZEBRAFISH;

EID: 77649226018     PISSN: 10842020     EISSN: None     Source Type: Journal    
DOI: 10.1093/ilar.50.4.373     Document Type: Article

References (64)

1. Ackermann GE, Paw BH. 2003. Zebrafish: A genetic model for vertebrate organogenesis and human disorders. Front Biosci 8:d1227-d1253.
2. Alvarez FA, Rodríguez-Martin I, Gonzalez-Nunez V, de Velasco EM, Gonzalez-Sarmiento R, Rodríguez RE. 2006. New kappa opioid receptor from zebrafish Danio rerio. Neurosci Lett 405:94-99.
3. Anichtchik OV, Kaslin J, Peitsaro N, Scheinin M, Panula P. 2004. Neurochemical and behavioural changes in zebrafish Danio rerio after systemic administration of 6-hydroxydopamine and 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine. J Neurochem 88:443-453.
4. Bally-Cuif L. 2006. Teleosts: Simple organisms? Complex behavior. Zebrafish 3:127-130.
5. Barrallo A, Gonzalez-Sarmiento R, Alvar F, Rodríguez RE. 2000. Zfor2, a new opioid receptor-like gene from the teleost zebrafish (Danio rerio). Brain Res Mol Brain Res 84:1-6.
6. Barrallo A, Gonzalez-Sarmiento R, Porteros A, Garcia-Isidoro M, Rodríguez RE. 1998a. Cloning, molecular characterization, and distribution of a gene homologous to delta opioid receptor from zebrafish (Danio rerio). Biochem Biophys Res Commun 245:544-548.
7. Barrallo A, Malvar FG, Gonzalez R, Rodríguez RE, Traynor JR. 1998b. Cloning and characterization of a delta opioid receptor from zebrafish. Biochem Soc Trans 26:S360.
8. Bretaud S, Li Q, Lockwood BL, Kobayashi K, Lin E, Guo S. 2007. A choice behavior for morphine reveals experience-dependent drug preference and underlying neural substrates in developing larval zebrafish. Neuroscience 146:1109-1116.
9. Brownstein MJ. 1993. A brief history of opiates, opioid peptides, and opioid receptors. Proc Natl Acad Sci U S A 90:5391-5393.
10. Capeyrou R, Riond J, Corbani M, Lepage JF, Bertin B, Emorine LJ. 1997. Agonist-induced signaling and trafficking of the mu-opioid receptor: Role of serine and threonine residues in the third cytoplasmic loop and c-terminal domain. FEBS Lett 415:200-205.
11. Darland T, Dowling JE. 2001. Behavioral screening for cocaine sensitivity in mutagenized zebrafish. Proc Natl Acad Sci U S A 98:11691-11696. den Hertog J. 2005. Chemical genetics: Drug screens in zebrafish. Biosci Rep 25:289-297.
12. Detrich HW 3rd, Westerfield M, Zon LI. 1999. Overview of the zebrafish system. Methods Cell Biol 59:3-10.
13. Dlugos CA, Rabin RA. 2003. Ethanol effects on three strains of zebrafish: Model system for genetic investigations. Pharmacol Biochem Behav 74:471-480.
14. Dooley K, Zon LI. 2000. Zebrafish: A model system for the study of human disease. Curr Opin Genet Dev 10:252-256.
15. Evans CJ. 2004. Secrets of the opium poppy revealed. Neuropharmacology 47 Suppl 1:293-299.
16. Fishman MC. 2001. Genomics. Zebrafish: The canonical vertebrate. Science 294:1290-1291.
17. Flinn L, Bretaud S, Lo C, Ingham PW, Bandmann O. 2008. Zebrafish as a new animal model for movement disorders. J Neurochem 106:1991-1997.
18. Gerlai R, Lahav M, Guo S, Rosenthal A. 2000. Drinks like a fish: Zebra fish (Danio rerio) as a behavior genetic model to study alcohol effects. Pharmacol Biochem Behav 67:773-782.
19. Goldsmith P. 2004. Zebrafish as a pharmacological tool: The how, why and when. Curr Opin Pharmacol 4:504-512.
20. Gonzalez-Nunez V, Gonzalez-Sarmiento R, Rodríguez RE. 2003a. Characterization of zebrafish proenkephalin reveals novel opioid sequences. Brain Res Mol Brain Res 114:31-39.
21. Gonzalez-Nunez V, Gonzalez-Sarmiento R, Rodríguez RE. 2003b. Cloning and characterization of a full-length pronociceptin in zebrafish: Evidence of the existence of two different nociceptin sequences in the same precursor. Biochim Biophys Acta 1629:114-118.
22. Gonzalez-Nunez V, Gonzalez-Sarmiento R, Rodríguez RE. 2003c. Identification of two proopiomelanocortin genes in zebrafish (Danio rerio). Brain Res Mol Brain Res 120:1-8.
23. Gonzalez-Nunez V, Arsequell G, Szemenyei E, Toth G, Valencia G, Rodríguez RE. 2005. Binding profile of the endogenous novel heptapeptide met-enkephalin-gly-tyr in zebrafish and rat brain. J Pharmacol Exp Ther 314:862-867.
24. Gonzalez-Nunez V, Barrallo A, Traynor JR, Rodríguez RE. 2006. Characterization of opioid-binding sites in zebrafish brain. J Pharmacol Exp Ther 316:900-904.
25. Gonzalez-Nunez V, Marron Fernandez de Velasco E, Arsequell G, Valencia G, Rodríguez RE. 2007a. Identification of dynorphin A from zebrafish: A comparative study with mammalian dynorphin A. Neuroscience 144:675-684.
26. Gonzalez-Nunez V, Toth G, Rodríguez RE. 2007b. Endogenous heptapeptide met-enkephalin-gly-tyr binds differentially to duplicate delta opioid receptors from zebrafish. Peptides 28:2340-2347.
27. Guo S. 2004. Linking genes to brain, behavior and neurological diseases: What can we learn from zebrafish? Genes Brain Behav 3:63-74.
28. Haffter P, Granato M, Brand M, Mullins MC, Hammerschmidt M, Kane DA, Odenthal J, van Eeden FJ, Jiang YJ, Heisenberg CP, Kelsh RN, Furutani-Seiki M, Vogelsang E, Beuchle D, Schach U, Fabian C, Nusslein-Volhard C. 1996. The identification of genes with unique and essential functions in the development of the zebrafish, Danio rerio. Development 123:1-36.
29. Hughes J. 1975. Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine. Brain Res 88:295-308.
30. Hughes J, Smith TW, Kosterlitz HW, Fothergill LA, Morgan BA, Morris HR. 1975. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 258:577-580.
31. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF. 1995. Stages of embryonic development of the zebrafish. Dev Dyn 203:253-310.
32. Langheinrich U. 2003. Zebrafish: A new model on the pharmaceutical catwalk. Bioessays 25:904-912.
33. Lapalu S, Moisand C, Mazarguil H, Cambois G, Mollereau C, Meunier JC. 1997. Comparison of the structure-activity relationships of nociceptin and dynorphin A using chimeric peptides. FEBS Lett 417:333-336.
34. Lau B, Bretaud S, Huang Y, Lin E, Guo S. 2006. Dissociation of food and opiate preference by a genetic mutation in zebrafish. Genes Brain Behav 5:497-505.
35. Lieschke GJ, Currie PD. 2007. Animal models of human disease: Zebrafish swim into view. Nat Rev Genet 8:353-367.
36. Lockwood B, Bjerke S, Kobayashi K, Guo S. 2004. Acute effects of alcohol on larval zebrafish: A genetic system for large-scale screening. Pharmacol Biochem Behav 77:647-654.
37. Love DR, Pichler FB, Dodd A, Copp BR, Greenwood DR. 2004. Technology for high-throughput screens: The present and future using zebrafish. Curr Opin Biotechnol 15:564-571.
38. Marron Fernandez de Velasco E, Law PY, Rodríguez RE. 2009. Mu opioid receptor from the zebrafish exhibits functional characteristics as those of mammalian μ-opioid receptor. Zebrafish (in press).
39. Martin NA, Ruckle MB, VanHoof SL, Prather PL. 2002. Agonist, antagonist, and inverse agonist characteristics of tipp (h-tyr-tic-phe-phe-oh), a selective delta-opioid receptor ligand. J Pharmacol Exp Ther 301:661-671.
40. Meunier JC, Mollereau C, Toll L, Suaudeau C, Moisand C, Alvinerie P, Butour JL, Guillemot JC, Ferrara P, Monsarrat B, Mazarguil H, Vassart G, Parmentier M, Costentin J. 1995. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377:532-535.
41. Meyer A, Schartl M. 1999. Gene and genome duplications in vertebrates: The one-to-four (-to-eight in fish) rule and the evolution of novel gene functions. Curr Opin Cell Biol 11:699-704.
42. Nestler EJ, Hope BT, Widnell KL. 1993. Drug addiction: A model for the molecular basis of neural plasticity. Neuron 11:995-1006.
43. Newport J, Kirschner M. 1982. A major developmental transition in early Xenopus embryos: I. Characterization and timing of cellular changes at the midblastula stage. Cell 30:675-686.
44. Ninkovic J, Bally-Cuif L. 2006. The zebrafish as a model system for assessing the reinforcing properties of drugs of abuse. Methods 39:262-274.
45. Peitsaro N, Kaslin J, Anichtchik OV, Panula P. 2003. Modulation of the histaminergic system and behaviour by alpha-fl uoromethylhistidine in zebrafish. J Neurochem 86:432-441.
46. Pert CB, Snyder SH. 1973. Opiate receptor: Demonstration in nervous tissue. Science 179:1011-1014.
47. Peterson RT, Shaw SY, Peterson TA, Milan DJ, Zhong TP, Schreiber SL, MacRae CA, Fishman MC. 2004. Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation. Nat Biotechnol 22:595-599.
48. Pichler FB, Laurenson S, Williams LC, Dodd A, Copp BR, Love DR. 2003. Chemical discovery and global gene expression analysis in zebrafish. Nat Biotechnol 21:879-883.
49. Pinal-Seoane N, Martin IR, Gonzalez-Nunez V, de Velasco EM, Alvarez FA, Sarmiento RG, Rodríguez RE. 2006. Characterization of a new duplicate delta-opioid receptor from zebrafish. J Mol Endocrinol 37:391-403.
50. Porteros A, Garcia-Isidoro M, Barrallo A, Gonzalez-Sarmiento R, Rodríguez RE. 1999. Expression of ZFOR1, a delta-opioid receptor, in the central nervous system of the zebrafish (Danio rerio). J Comp Neurol 412:429-438.
51. Reinscheid RK, Ardati A, Monsma FJ Jr, Civelli O. 1996. Structure-activity relationship studies on the novel neuropeptide orphanin FQ. J Biol Chem 271:14163-14168.
52. Rodríguez RE, Barrallo A, Garcia-Malvar F, McFadyen IJ, Gonzalez-Sarmiento R, Traynor JR. 2000. Characterization of ZFOR1, a putative delta-opioid receptor from the teleost zebrafish (Danio rerio). Neurosci Lett 288:207-210.
53. Saint-Amant L, Drapeau P. 1998. Time course of the development of motor behaviors in the zebrafish embryo. J Neurobiol 37:622-632.
54. Sanchez-Simon FM, Rodríguez RE. 2008. Developmental expression and distribution of opioid receptors in zebrafish. Neuroscience 151:129-137.
55. Shin JT, Fishman MC. 2002. From zebrafish to human: Modular medical models. Annu Rev Genomics Hum Genet 3:311-340.
56. Sidow A. 1996. Gen(om)e duplications in the evolution of early vertebrates. Curr Opin Genet Dev 6:715-722.
57. Simon EJ, Hiller JM, Edelman I. 1973. Stereospecific binding of the potent narcotic analgesic (3h) etorphine to rat-brain homogenate. Proc Natl Acad Sci U S A 70:1947-1949.
58. Sneddon LU. 2009. Pain perception in fish: Indicators and endpoints. ILAR J 50:338-342.
59. Sneddon LU, Braithwaite VA, Gentle MJ. 2003. Do fishes have nociceptors? Evidence for the evolution of a vertebrate sensory system. Proc Biol Sci 270:1115-1121.
60. Snyder SH. 1996. Drugs and the Brain. New York: WH Freeman.
61. Stoletov K, Klemke R. 2008. Catch of the day: Zebrafish as a human cancer model. Oncogene 27:4509-4520.
62. Terenius L. 1973. Stereospecific interaction between narcotic analgesics and a synaptic plasma membrane fraction of rat cerebral cortex. Acta Pharmacol Toxicol (Copenh) 32:317-320.
63. Volpato GL. 2009. Challenges in assessing fish welfare. ILAR J 50:329-337.
64. Zon LI, Peterson RT. 2005. In vivo drug discovery in the zebrafish. Nat Rev Drug Discov 4:35-44.